Vidalta 10 mg tablets for Oral Use for Cats
Страна: Венгрия
Язык: английский
Источник: HMA (Heads of Medicines Agencies)
Характеристики продукта
(SPC)
16-03-2013
Некоторые документы для этого продукта в настоящее время недоступны, вы можете отправить запрос в нашу службу поддержки, и мы сообщим вам, как только мы сможем их получить.
Послать запрос.
Послать запрос.
Активный ингредиент:
carbimazole 10 mg
Доступна с:
Intervet Intenational BV
код АТС:
QH03BB01
Фармацевтическая форма:
Tablet
Терапевтическая группа:
carbimazole
Терапевтические области:
Cats
Дата Авторизация:
2011-10-26
Характеристики продукта
Revised: January 2012
AN: 02006/2010
Page 1 of 8
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Vidalta 10 mg prolonged-release tablets for cats
BE, NO: Vidalta Vet 10 mg prolonged-release tablets for cats
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each prolonged-release tablet contains:
ACTIVE SUBSTANCE:
Carbimazole
10.00 mg
EXCIPIENTS:
Red ferric oxide (E172)
0.25 mg
For a full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Prolonged-release tablet
Round pink tablet with little spots
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cat
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of hyperthyroidism and hyperthyroidism-associated clinical signs in cats
4.3
CONTRAINDICATIONS
Do not use in cats suffering from concurrent systemic diseases, such as severe primary
liver disease or diabetes mellitus.
Do not use in cats showing signs of auto-immune diseases and/or altered red or white
blood cell counts, such as anaemia, neutropaenia or lymphopaenia.
Revised: January 2012
AN: 02006/2010
Page 2 of 8
Do not use in cats with platelet disorders (particularly thrombocytopaenia) or
coagulopathies.
Do not use in cats with hypersensitivity to mercaptoimidazoles (carbimazole or
thiamazole (methimazole))
Please refer to section 4.7.
4.4
SPECIAL WARNINGS FOR THE TARGET SPECIES
Thiamazole (methimazole), the active metabolite of carbimazole, inhibits thyroid
hormone production and therefore cessation of treatment with carbimazole will result in
a r
Прочитать полный документ
